The Difference Between Platelet and Plasma FXIII Used to Study the Mechanism of Platelet Microvesicle Formation

Summary

The formation of microvesicles from platelets was induced either by activation of the complement system by a monoclonal antibody to CD9, or by incubation of platelets with the calcium ionophore A23187. A filter technique to isolate the microvesicles without plasma contamination is described. The microvesicles contained FXIIIa₂ from the platelet cytoplasm which shows that these particles contain significant amounts of intracellular material. This was shown by the use of crossed immunoelectrophoresis with rabbit antibodies to total human platelet proteins in the second dimension gel and polyclonal antibodies against the a- and b-subunit of FXIII in the intermediate gel. The FXIIIa₂ in the microvesicle was found to be functional as an enzyme. To prove this, it was shown that FXIII in its immunoprecipitate arc could catalyze the incorporation of monodansylcadaverine into casein as identified by fluorescence of this arc in ultraviolet light. The observation that the plasma form of FXIII (FXIIIa₂b₂) was absent from the microvesicles collected by the filtration technique, whereas it was present in platelet fragments obtained by mechanical disruption by ultrasonication, indicates that the activation-dependent microvesicles are formed by a true budding process with the inclusion of intracellular, but not extracellular material.

• References

• 1 Lopaciuk S, Lovette KM, Mcdonagh J, Chuang HYK, Mcdonagh RP. Subcellular distribution of fibrinogen and Factor XIII in human blood platelets. Thromb Res 1976; 8: 453-465
• 2 Gogstad GO, Hagen I, Korsmo R, Solum NO. Evidence for release of soluble, but not of membrane-integrated proteins from human platelets alpha-granules. Biochim Biophys Acta 1981; 702: 81-89
• 3 Schwartz ML, Pizzo SV, Hill RL, Mcee PA. The subunit structure of human plasma and platelet factor XIII. J Biol Chem 1971; 246: 5851-5851
• 4 Lorand L. Fibrinoligase: The fibrin-stabilizing factor system of blood plasma. Ann NY Acad Sci 1972; 202: 6-29
• 5 Mosher DF. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 1975; 250: 6614-6621
• 6 Hagen I, Bjerrum OJ, Solum NO. Characterization of human platelet proteins solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Eur J Biochem 1979; 99: 9
• 7 Solum NO, Olsen TM. Glycoprotein lb in the Triton-insoluble (cytoskeletal) fraction of blood platelets. Biochem Biophys Acta 1984; 799: 209-220
• 8 Gogstad GO, Brosstad F. Platelet Factor XIII is an active enzyme after solubilization and crossed immunoelectrophoresis. Thromb Res 1983; 29: 237-241
• 9 Lorand L, Uruyama T, deKiewiet JWC, Nossel HL. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest 1969; 48: 1054-1064
• 10 Bevers. et al Phospholipid transbilayer asymmetry in artificially induced platelet plasma membrane vesicles. Biochim Biophys Acta 1987; 903: 197-205
• 11 Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. J Biol Chem 1988; 263: 18205-18212
• 12 Ando Y, Imamura S, Yamagata Y, Kitahara A, Saji H, Murachi T, Kannagi R. Platelet factor XIII is activated by calpain. Biochem Biophys Res Commun 1987; 144: 484-490
• 13 Muszbek L, Polgar J, Boda Z. Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb Haemostas 1993; 69: 282-285